Morse Asset Management’s Gilead Sciences GILD Stock Holding History

Morse Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$506K	Sell	3,629 -6,271	-63%	-$878K	0.11%	125
2025 Q4	$1.22M	Buy	+9,900	New	+$1.2M	0.24%	81
2019 Q3	–	Sell	-17,655	Closed	-$1.19M	–	130
2019 Q2	$1.19M	Sell	17,655 -18,520	-51%	-$1.22M	0.35%	69
2019 Q1	$2.35M	Sell	36,175 -11,450	-24%	-$761K	0.71%	42
2018 Q4	$2.98M	Sell	47,625 -1,860	-4%	-$130K	1.06%	30
2018 Q3	$3.82M	Buy	49,485 +4,950	+11%	+$374K	1.01%	29
2018 Q2	$3.15M	Sell	44,535 -7,585	-15%	-$536K	0.86%	36
2018 Q1	$3.93M	Buy	52,120 +10,940	+27%	+$870K	1.09%	29
2017 Q4	$2.95M	Buy	41,180 +2,080	+5%	+$158K	0.82%	40
2017 Q3	$3.17M	Buy	39,100 +13,340	+52%	+$1.02M	0.94%	35
2017 Q2	$1.82M	Sell	25,760 -5,850	-19%	-$389K	0.59%	57
2017 Q1	$2.15M	Buy	+31,610	New	+$2.22M	0.73%	47

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morse Asset Management's GILD Position: Q1 2026 in Review

Morse Asset Management reduced its Gilead Sciences (GILD) stake by 63% in Q1 2026, selling an estimated $878K and leaving 3,629 shares worth $506K. The position accounts for 0.11% of the portfolio, ranked #125.

Morse Asset Management first reported a position in GILD in Q1 2017 and has held it in 12 quarters since. The position peaked at $3.93M in Q1 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Morse Asset Management held 3,629 shares of Gilead Sciences worth $506K as of Q1 2026.
Morse Asset Management sold 6,271 Gilead Sciences shares in Q1 2026, an estimated $878K.
Gilead Sciences made up 0.11% of Morse Asset Management's portfolio in Q1 2026, its #125 holding.
Morse Asset Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 12 quarters since.
Morse Asset Management's Gilead Sciences position peaked at $3.93M in Q1 2018.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Morse Asset Management's 13F filing for Q1 2026, filed 14 May 2026.